Oxygen News and Research

RSS

Study connects hyperglycemia and prolonged cloth mask use to COVID-19-associated mucormycosis risk

A new study conducted in India identifies the role of high blood sugar levels in predisposing patients to mucormycosis infection.

1 Aug 2021

Study paves the way to a new drug design concept

Hydrogen peroxide reacts with copper to produce hydroxyl radicals with strong antibacterial properties. However, this requires high copper concentrations because two copper atoms have to come close together, which occurs by chance.

31 Jul 2021

Research finds associations between COVID-19 and persistent cognitive deficits

Much has been learned about SARS-CoV-2, the virus that causes the novel coronavirus, since the beginning of the COVID-19 pandemic. However, questions remain about the long-term impact of the virus on our bodies and brains.

29 Jul 2021

Covid renews interest in radiation, but docs caution against pilgrimages to radon-filled mines

Twice a year, Brian Tichenor makes the 1,200-mile drive each way from his home in Kansas to a defunct uranium mine in Montana, where he takes an elevator 85 feet below the surface to sit amid radioactive radon gas to ease the pain from his chronic eye condition.

29 Jul 2021

How SARS-CoV-2 variants effect maternal infection and pregnancy

A new study focuses on the impact of SARS-CoV-2 on maternal and perinatal outcomes.

28 Jul 2021

Natural compound prevents, reverses brain damage linked to Parkinson's disease in mice

Johns Hopkins Medicine researchers say they have added to evidence that the compound farnesol, found naturally in herbs, and berries and other fruits, prevents and reverses brain damage linked to Parkinson's disease in mouse studies.

28 Jul 2021

People with OSA have greater risk of sudden death and cardiovascular conditions

A study by Penn State College of Medicine researchers reveals that people living with obstructive sleep apnea (OSA), a condition that occurs when a person's airway becomes blocked while they are asleep, are twice as likely to experience sudden death compared to people living without OSA.

28 Jul 2021

Study reveals disparities in heart failure diagnosis within clinical practices

Many heart failure diagnoses may be missed in a primary care setting. Women, Black adults and individuals with lower net worth are significantly more likely to be diagnosed with heart failure in an acute care setting such as the emergency room or during a hospitalization, even if they reported symptoms of heart failure during a routine, outpatient health care appointment during the previous six months, according to new research published today in Circulation: Heart Failure, an American Heart Association journal.

27 Jul 2021

Freiburg surgeons develop new treatment method to improve survival after cardiac arrest

Around 50,000 people suffer sudden cardiac arrest in Germany every year. When occurring outside a hospital, the chances of survival are only ten percent. Survivors often suffer from severe permanent neurological damage.

23 Jul 2021

Research provides vital insights about excess coffee consumption and brain health

It's a favorite first-order for the day, but while a quick coffee may perk us up, new research from the University of South Australia shows that too much could be dragging us down, especially when it comes to brain health.

22 Jul 2021

Pfizer vaccine and isolation independently associated with reduced household transmission of SARS-CoV-2

Israel was among the leading proponents of COVID-19 vaccination as the way out of the current worldwide restrictions on social and economic interactions and activity. A new study, recently released as a preprint on the medRxiv* server, reports on the effects of the large-scale vaccination campaigns carried out in this country, relating to successful control of SARS-CoV-2 spread within households.

22 Jul 2021

Study evaluates physical activity and sedentary behavior in relation to OSA risk

Being more physically active and spending fewer hours per day sitting watching TV is linked to a substantially lower risk of developing obstructive sleep apnea (OSA), according to new research published in the European Respiratory Journal

21 Jul 2021

IQWiG finds no benefit of high-flow therapy for COPD and type 1 respiratory failure

No benefit of high-flow therapy (HFT) can be derived from the available study data for patients with advanced chronic obstructive pulmonary disease (COPD) or chronic type 1 respiratory failure. It therefore remains unclear whether this form of treatment has advantages over long-term oxygen therapy (LTOT) or non-invasive ventilation (NIV).

20 Jul 2021

MCG scientists find copper transporter as potential therapeutic target for cardiovascular diseases

An internal transporter that enables us to use the copper we consume in foods like shellfish and nuts to enable a host of vital body functions also has the essential role of protecting the receptor that enables us to grow new blood vessels when ours become diseased, Medical College of Georgia scientists report.

20 Jul 2021

Redhill Biopharma announces completion of Phase 2/3 COVID-19 study of oral opaganib

RedHill Biopharma Ltd., a specialty pharma company that is a leader in the development of novel oral therapies for COVID-19, today announced that all treatment and follow-up has now been completed in the 475-patient global Phase 2/3 study with opaganib (ABC294640) in patients hospitalized with severe COVID-19 pneumonia (NCT04467840). Top-line results are expected in the coming weeks.

20 Jul 2021

Deadly spider venom could help prevent damage from heart attacks

A potentially life-saving treatment for heart attack victims has been discovered from a very unlikely source - the venom of one of the world's deadliest spiders.

19 Jul 2021

Study reveals the impact of high respiratory efforts on the lungs of COVID-19 patients

The impact of high breathing efforts on the lungs of patients suffering with acute respiratory failure due to COVID-19 has been investigated by researchers at the University of Warwick, who assessed the likelihood of resulting lung injury.

19 Jul 2021

Oxygen therapy may improve hypoxia-induced B cell abnormalities in COVID-19

Researchers in the United States have demonstrated early and persistent B cell abnormalities in patients with moderate or severe coronavirus disease 2019 (COVID-19) that may be largely driven by hypoxia.

18 Jul 2021

New live cell models lay the groundwork for studies into mitochondrial diseases

The mitochondrion has garnered quite the reputation for its role as the "powerhouse of the cell." These tiny, but mighty organelles play various life-sustaining roles, from powering our own cells and organs to fueling chemical and biological processes.

15 Jul 2021

Antihypertension drug may benefit patients with neurofibromatosis type 2

New research led by investigators at Massachusetts General Hospital and Massachusetts Eye and Ear indicates that the blood pressure drug losartan may benefit patients with neurofibromatosis type 2 (NF2), a hereditary condition associated with vestibular schwannomas, or noncancerous tumors along the nerves in the brain that are involved with hearing and balance.

15 Jul 2021

Oxygen News and Research

Study connects hyperglycemia and prolonged cloth mask use to COVID-19-associated mucormycosis risk

Study paves the way to a new drug design concept

Research finds associations between COVID-19 and persistent cognitive deficits

Covid renews interest in radiation, but docs caution against pilgrimages to radon-filled mines

How SARS-CoV-2 variants effect maternal infection and pregnancy

Natural compound prevents, reverses brain damage linked to Parkinson's disease in mice

People with OSA have greater risk of sudden death and cardiovascular conditions

Study reveals disparities in heart failure diagnosis within clinical practices

Freiburg surgeons develop new treatment method to improve survival after cardiac arrest

Research provides vital insights about excess coffee consumption and brain health

Pfizer vaccine and isolation independently associated with reduced household transmission of SARS-CoV-2

Study evaluates physical activity and sedentary behavior in relation to OSA risk

IQWiG finds no benefit of high-flow therapy for COPD and type 1 respiratory failure

MCG scientists find copper transporter as potential therapeutic target for cardiovascular diseases

Redhill Biopharma announces completion of Phase 2/3 COVID-19 study of oral opaganib

Deadly spider venom could help prevent damage from heart attacks

Study reveals the impact of high respiratory efforts on the lungs of COVID-19 patients

Oxygen therapy may improve hypoxia-induced B cell abnormalities in COVID-19

New live cell models lay the groundwork for studies into mitochondrial diseases

Antihypertension drug may benefit patients with neurofibromatosis type 2

Oxygen Measurement eBook - Easily Understand Dissolved Oxygen Measurement eBook

Latest eBooks

Industry Focus eBook - Microbiome (1st edition)

Industry Focus eBook - Cell biology (5th edition)

Advancing degrader and proximity-based drug development

Driving innovation in Korean drug development

Advancing Intracellular Delivery with LumiPore®

How ELRIG Is Helping Mid-Career Scientists Navigate Leadership, Career Change and Redundancy

The role of UV-Vis in biopharma QC